We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUV
3726
DELISTED
Arcimoto, Inc. Common Stock
FUV
$142K ﹤0.01%
+1,073
New +$139K
FWP
3727
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$142K ﹤0.01%
24,500
-17,100
-41% -$95.4K
FGNX
3728
FG Nexus Inc
FGNX
$41.6M
$141K ﹤0.01%
415
-89
-18% -$35.8K
JFIN
3729
Jiayin Group
JFIN
$113M
$141K ﹤0.01%
51,100
-73,300
-59% -$164K
VIGL
3730
DELISTED
Vigil Neuroscience
VIGL
$141K ﹤0.01%
+20,041
New +$264K
ASAP
3731
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$141K ﹤0.01%
18,999
-3,001
-14% -$31.1K
YGMZ
3732
DELISTED
MingZhu Logistics Holdings
YGMZ
$139K ﹤0.01%
537
-452
-46% -$95.4K
CPHI icon
3733
China Pharma Holdings
CPHI
$45M
$138K ﹤0.01%
709
-211
-23% -$44K
CXDO icon
3734
Crexendo
CXDO
$223M
$138K ﹤0.01%
37,886
-11,714
-24% -$48.6K
JP
3735
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$137K ﹤0.01%
190,825
+2,500
+1% +$1.83K
NDRA icon
3736
ENDRA Life Sciences
NDRA
$5.97M
$136K ﹤0.01%
10
+4
+67% +$71.7K
TWAV
3737
TaoWeave Inc
TWAV
$4.49M
$136K ﹤0.01%
347
-58
-14% -$25.9K
TPST icon
3738
Tempest Therapeutics
TPST
$13.7M
$136K ﹤0.01%
3,092
-787
-20% -$35.7K
BLNE
3739
Beeline Holdings
BLNE
$28.8M
$136K ﹤0.01%
710
-1,001
-59% -$228K
AUMN
3740
DELISTED
Golden Minerals Company
AUMN
$136K ﹤0.01%
10,858
-144
-1% -$1.63K
LIAN
3741
DELISTED
LianBio American Depositary Shares
LIAN
$136K ﹤0.01%
+36,524
New +$151K
TIG
3742
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$136K ﹤0.01%
29,100
+14,000
+93% +$94.4K
CMMB
3743
Chemomab Therapeutics
CMMB
$11.4M
$134K ﹤0.01%
+6,990
New +$138K
IMNN icon
3744
Imunon
IMNN
$6.68M
$134K ﹤0.01%
2,036
+1,481
+267% +$116K
TBLA icon
3745
Taboola.com
TBLA
$1.37B
$134K ﹤0.01%
25,900
+11,900
+85% +$73.3K
HSDT icon
3746
Solana Company
HSDT
$96.3M
$133K ﹤0.01%
1
RMTI icon
3747
Rockwell Medical
RMTI
$28.4M
$133K ﹤0.01%
2,557
+507
+25% +$21.5K
MYSE
3748
Myseum.AI Inc
MYSE
$11M
$130K ﹤0.01%
+4,950
New +$110K
SEI
3749
Solaris Energy Infrastructure
SEI
$3.15B
$130K ﹤0.01%
11,500
-79,100
-87% -$716K
AGRX
3750
DELISTED
Agile Therapeutics
AGRX
$130K ﹤0.01%
311
+230
+284% +$147K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.